This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Laivuori, H. Articles by Ylikorkala, O. Search for Related Content PubMed PubMed Citation Articles by Laivuori, H. Articles by Ylikorkala, O.

Evidence of High Circulating Testosterone in Women with Prior Preeclampsia¹

Department of Obstetrics and Gynecology, and Clinical Chemistry, Helsinki University Central Hospital, Finland

Address all correspondence and requests for reprints to: Hannele Laivuori, Department of Obstetrics and Gynecology, University Central Hospital of Helsinki, Haartmaninkatu 2, FIN-00290 Helsinki, Finland. E-mail: hannele.laivuori{at}pp.fimnet.fi

Women with prior preeclampsia are characterized by hyperinsulinemia and a 2- to 3-fold excess risk of hypertension and ischemic heart disease in later life. We therefore studied whether these women present changes in pituitary, ovarian, and endothelial factors that could also affect the risk of vascular disorders. Twenty-two women with prior preeclampsia and 22 control women matched by age and body mass index were studied an average of 17 yr after delivery. Women with prior preeclampsia had elevated serum free testosterone levels (20.6 ± 2.2 vs. 15.0 ± 1.3 pmol/L, mean ± SE, P = 0.03), an elevated free androgen index (3.2 ± 0.5 vs. 1.9 ± 0.2, P = 0.04), and an elevated free testosterone estradiol ratio (0.089 ± 0.017 vs. 0.046 ± 0.006, P = 0.02). The levels of insulin-like growth factor binding protein-1 decreased as expected during a 3-h oral glucose tolerance test without differences between the groups. Levels of FSH, LH, androstenedione, dehydroepiandrosterone sulfate, and endothelin-1, as well as urinary output of prostacyclin and thromboxane A₂ metabolites, showed no difference between study groups. A history of preeclampsia an average of 17 yr earlier thus appears to be associated with elevated levels of testosterone, which may contribute to the increased risk of vascular morbidity in such women.

This article has been cited by other articles:

				G. Paradisi, A. Biaggi, R. Savone, F. Ianniello, C. Tomei, L. Caforio, and A. Caruso Cardiovascular Risk Factors in Healthy Women with Previous Gestational Hypertension J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1233 - 1238. [Abstract] [Full Text] [PDF]

				R. J. Kaaja and I. A. Greer Manifestations of Chronic Disease During Pregnancy JAMA, December 7, 2005; 294(21): 2751 - 2757. [Abstract] [Full Text] [PDF]

				J. M. Roberts and H. S. Gammill Preeclampsia: Recent Insights Hypertension, December 1, 2005; 46(6): 1243 - 1249. [Abstract] [Full Text] [PDF]

				H. Vasudevan, H. Xiang, and J. H. McNeill Differential regulation of insulin resistance and hypertension by sex hormones in fructose-fed male rats Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1335 - H1342. [Abstract] [Full Text] [PDF]

				M.A. Checa, A. Requena, C. Salvador, R. Tur, J. Callejo, J.J. Espinos, F. Fabregues, J. Herrero, and (Reproductive Endocrinology Interest Group of the Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome Hum. Reprod. Update, July 1, 2005; 11(4): 375 - 390. [Abstract] [Full Text] [PDF]

				R. Kaaja, T. Kinnunen, and R. Luoto Regional differences in the prevalence of pre-eclampsia in relation to the risk factors for coronary artery disease in women in Finland Eur. Heart J., January 1, 2005; 26(1): 44 - 50. [Abstract] [Full Text] [PDF]

				E. Vanky, K.A. Salvesen, R. Heimstad, K.J. Fougner, P. Romundstad, and S.M. Carlsen Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study Hum. Reprod., August 1, 2004; 19(8): 1734 - 1740. [Abstract] [Full Text] [PDF]

				E. W. Seely and C. G. Solomon Insulin Resistance and Its Potential Role in Pregnancy-Induced Hypertension J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2393 - 2398. [Abstract] [Full Text] [PDF]

				A. Tiitinen Obstetric outcome in women with polycystic ovarian syndrome Hum. Reprod., July 1, 2001; 16(7): 1537 - 1537. [Full Text] [PDF]

				M. Mikola, V. Hiilesmaa, M. Halttunen, L. Suhonen, and A. Tiitinen Obstetric outcome in women with polycystic ovarian syndrome Hum. Reprod., February 1, 2001; 16(2): 226 - 229. [Abstract] [Full Text] [PDF]

				H. LAIVUORI, R. KAAJA, U. TURPEINEN, L. VIINIKKA, and O. YLIKORKALA Plasma Homocysteine Levels Elevated and Inversely Related to Insulin Sensitivity in Preeclampsia Obstet. Gynecol., April 1, 1999; 93(4): 489 - 493. [Abstract] [Full Text] [PDF]